EMA Orphan Drug Designation (ODD) builds on U.S. Food Drug Administration (FDA) ODD and Fast Track Designation, underscoring the urgent need for new treatment optionsThe multiple regulatory…Read More
You might also be interested in reading Outcome of Zakinov vs. Ripple to Affect 75,890 XRP Holders.